REA Process & Licensing

Facilitating Access to Cutting-Edge Cellular Solutions 

Experience Our Technology Firsthand

At Pluristyx, we believe in the transformative potential of our cellular products, and we want you to experience their capabilities firsthand. That’s why we offer a unique opportunity through our Research Evaluation Agreement, a pathway that grants you access to our edited and non-edited cellular products for evaluation, all within our innovative “Try Before You Buy” model. This approach is designed to minimize your upfront financial commitment while maximizing your ability to explore the full potential of our technology. 

Research Evaluation Agreement Process

More Informed Decisions

This approach is a game-changer for researchers and organizations seeking to harness the power of iPSCs. Instead of committing to a commercial license agreement right away, you have the opportunity to experiment, assess, and witness the results our cellular products can deliver. It‘s a risk-limiting strategy that allows you to make informed decisions based on your own firsthand experience. 

Advancing Scientific Innovation

At Pluristyx, we are passionate about advancing scientific innovation, and we want to be your partner on that journey. Our Research Evaluation Agreement and Try Before You Buy approach are clear demonstrations of our commitment to facilitating your access to cutting-edge cellular solutions. With Pluristyx, you don’t just read about the technology; you get to experience it firsthand, making informed decisions that drive your research and development forward. Join us in shaping the future of cellular science. 

Explore More

iACT

Technology
Our groundbreaking iACT technology with immune-modulatory genes allows the acceptance of allografts without the need for systemic immune suppression. Equipping pluripotent stem cells with this technology will allow the same cell line to be used for differentiation and ultimately transplantation into any individual.
Learn more

Development Services

Solutions
Pluristyx excels at tackling the most challenging aspects of the product lifecycle, giving you the time to concentrate on what you do best.
Learn More

FailSafe®

Technology
A reliable safeguard against transplants becoming tumorigenic – any unwanted cells can be eliminated with a simple source of drug treatment.
Shop now

iACT

Technology
Our groundbreaking iACT technology with immune-modulatory genes allows the acceptance of allografts without the need for systemic immune suppression. Equipping pluripotent stem cells with this technology will allow the same cell line to be used for differentiation and ultimately transplantation into any individual.
Learn more

Development Services

Solutions
Pluristyx excels at tackling the most challenging aspects of the product lifecycle, giving you the time to concentrate on what you do best.
Learn More

FailSafe®

Technology
A reliable safeguard against transplants becoming tumorigenic – any unwanted cells can be eliminated with a simple source of drug treatment.
Shop now
Contact Us

Scroll to Top